Literature DB >> 9950661

Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium.

G Hasenfuss1, W Schillinger, S E Lehnart, M Preuss, B Pieske, L S Maier, J Prestle, K Minami, H Just.   

Abstract

BACKGROUND: In the failing human heart, sarcoplasmic reticulum (SR) calcium handling is impaired, and therefore, calcium elimination and diastolic function may depend on the expression of sarcolemmal Na+-Ca2+ exchanger. METHODS AND
RESULTS: Force-frequency relations were studied in ventricular muscle strip preparations from failing human hearts (n=29). Protein levels of Na+-Ca2+ exchanger and SR Ca2+-ATPase were measured in the same hearts. Hearts were divided into 3 groups by discriminant analysis according to the behavior of diastolic function when stimulation rate of muscle strips was increased from 30 to 180 min-1. At 180 compared with 30 min-1, diastolic force was increased by 160%, maximum rate of force decline was decreased by 46%, and relaxation time was unchanged in group III. In contrast, in group I, diastolic force and maximum rate of force decline did not change, and relaxation time decreased by 20%. Na+-Ca2+ exchanger was 66% higher in group I than in group III. Na+-Ca2+ exchanger was inversely correlated with the frequency-dependent rise of diastolic force when stimulation rate was increased (r=-0.74; P<0.001). Compared with nonfailing human hearts (n=6), SR Ca2+-ATPase was decreased and Na+-Ca2+ exchanger unchanged in group III, whereas Na+-Ca2+ exchanger was increased and SR Ca2+-ATPase unchanged in group I. Results with group II hearts were between those of group I and group III hearts.
CONCLUSIONS: By discriminating failing human hearts according to their diastolic function, we identified different phenotypes. Disturbed diastolic function occurs in hearts with decreased SR Ca2+-ATPase and unchanged Na+-Ca2+ exchanger, whereas increased expression of the Na+-Ca2+ exchanger is associated with preserved diastolic function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950661     DOI: 10.1161/01.cir.99.5.641

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  118 in total

Review 1.  Cardiac signal transduction.

Authors:  K H Lee; R J Hajjar; T Matsui; G Choukroun; T L Force; A Rosenzweig
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

Review 2.  The sodium/calcium exchanger family-SLC8.

Authors:  Beate D Quednau; Debora A Nicoll; Kenneth D Philipson
Journal:  Pflugers Arch       Date:  2003-05-07       Impact factor: 3.657

Review 3.  Targeting calcium cycling proteins in heart failure through gene transfer.

Authors:  Federica del Monte; Roger J Hajjar
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

4.  Non-steady-state calcium handling in failing hearts from the spontaneously hypertensive rat.

Authors:  Marie-Louise Ward; David J Crossman; Denis S Loiselle; Mark B Cannell
Journal:  Pflugers Arch       Date:  2010-09-21       Impact factor: 3.657

5.  Changes in intracellular Na+ in heart failure following SERCA knockout--more of a solution or more of a problem?

Authors:  J Andrew Wasserstrom
Journal:  J Physiol       Date:  2010-04-01       Impact factor: 5.182

Review 6.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

7.  ACE inhibition prevents diastolic Ca2+ overload and loss of myofilament Ca2+ sensitivity after myocardial infarction.

Authors:  S Zalvidea; L André; X Loyer; C Cassan; Y Sainte-Marie; J Thireau; I Sjaastad; C Heymes; J-L Pasquié; O Cazorla; F Aimond; S Richard
Journal:  Curr Mol Med       Date:  2012-02       Impact factor: 2.222

8.  Sodium accumulation promotes diastolic dysfunction in end-stage heart failure following Serca2 knockout.

Authors:  William E Louch; Karina Hougen; Halvor K Mørk; Fredrik Swift; Jan M Aronsen; Ivar Sjaastad; Henrik M Reims; Borghild Roald; Kristin B Andersson; Geir Christensen; Ole M Sejersted
Journal:  J Physiol       Date:  2009-12-14       Impact factor: 5.182

9.  In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failure.

Authors:  Anuradha Guggilam; Kirk R Hutchinson; T Aaron West; Amy P Kelly; Maarten L Galantowicz; Amy J Davidoff; Sakthivel Sadayappan; Pamela A Lucchesi
Journal:  J Mol Cell Cardiol       Date:  2012-12-07       Impact factor: 5.000

Review 10.  Transcriptional pathways and potential therapeutic targets in the regulation of Ncx1 expression in cardiac hypertrophy and failure.

Authors:  Donald R Menick; Mona S Li; Olga Chernysh; Ludivine Renaud; Denise Kimbrough; Harinath Kasiganesan; Santhosh K Mani
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.